Clinical Pharmacology

Bioanalysis, Biomarker and Flow Cytometry Assay List

Bioanalysis, Biomarker and Flow Cytometry Assay List. PRA Laboratories—Solutions for Drug Development. Behind every sample waiting to be analyzed,…

Healthcare Intelligence: Q&A with Ewoud-Jan van Hoogdalem

How can we keep healthcare affordable and accessible to all? How can we use science to benefit humans? Asking Ewoud-Jan van Hoogdalem a question…

Sustainability

We’re committed to meaningfully integrating sustainability considerations into our business practices and culture. The work we do has a global…

Company History

A Blueprint to Success: Onboarding a Medical Writer

Onboarding is the process of welcoming new employees into an organization and providing them with the tools, resources, and knowledge to become…

Oral Abuse Potential of Benzhydrocodone, a Novel Prodrug of Hydrocodone

Hydrocodone bitartrate (HB) and acetaminophen (APAP) combination products are known to be abused via oral, intranasal, and intravenous…

Select Characteristics of Recreational Opioid Users Undergoing a Human Abuse Potential Study

Human abuse potential (HAP) studies are conducted to determine the potential abuse of a drug that has rewarding properties. Abuse potential refers to…

Predicting Screen Failure Rates of Human Abuse Potential Studies

Human Abuse Potential (HAP) studies are required for New Drug Approvals of all drugs that have a potential psychoactive effect. The steps of…

Human Abuse Liability Studies: Not Your Traditional Phase I Study

Abuse potential refers to the likelihood for a drug to be used in nonmedical situations for its positive psychoactive effects. PRA Health Sciences’…

Pharmacokinetic Charcateristic of Oral_Intranasal Morphine ARER

Extended-release (ER) opioid formulations are often targeted for misuse and abuse because they contain high amounts of opioid. An oral…